Can-Fite BioPharma Ltd. Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Can-Fite BioPharma Ltd. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q4 2023.
  • Can-Fite BioPharma Ltd. Common Stock, Shares, Outstanding for the quarter ending December 31, 2023 was 1.36B shares, a 66.7% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 1.36B +544M +66.7% Dec 31, 2023 20-F 2024-03-28
Q2 2023 1.22B +409M +50.1% Jun 30, 2023 6-K 2023-08-31
Q4 2022 816M 0 0% Dec 31, 2022 20-F 2024-03-28
Q2 2022 816M +300M +58.2% Jun 30, 2022 6-K 2022-08-25
Q4 2021 816M +352M +75.9% Dec 31, 2021 20-F 2023-03-30
Q2 2021 516M +104M +25.4% Jun 30, 2021 6-K 2021-08-26
Q4 2020 464M +343M +284% Dec 31, 2020 20-F 2022-03-24
Q2 2020 411M Jun 30, 2020 6-K 2020-08-27
Q4 2019 121M +80.3M +199% Dec 31, 2019 20-F 2021-03-25
Q4 2018 40.4M Dec 31, 2018 6-K 2020-06-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.